Convatec Group PLC

CTEC: XLON (GBR)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|LtLOCK|b<HR<LOCK|xPRXs?

Convatec Earnings: Solid Mid-Single-Digit Growth, Despite Reimbursement Headwinds

Convatec reported abbreviated third-quarter results that featured 5% revenue growth year over year, supported by mid-single-digit growth from advanced wound care and double-digit increases from the smaller infusion care product line.

Sponsor Center